HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancerJie Xu, Rui Chen, Jun Yeon Yun et al.|Cell Death and Disease|2021Cited by 64
Corrigendum to “Investigation of the enhanced antitumor potency of CD46-specific chimeric antigen receptor-T cells in human colorectal cancer liver metastases after combination with nanotherapeutics”[Nano Today, 52 (2023), 101985]Qingtao Meng, Rui Chen, Jie Xu et al.|Nano Today|2024Cited by 0